Sarah Cannon Development Innovations

Sarah Cannon Development Innovations is the full-service contract research organization (CRO) arm of the Sarah Cannon Research Institute, specializing in oncology clinical development. The company provides comprehensive clinical trial management services, including study design, regulatory support, site monitoring, and data management, specifically tailored for early-phase and late-phase cancer research. By leveraging its deep integration with HCA Healthcare and its extensive network of clinical sites, it offers biotech and pharmaceutical partners accelerated access to patient populations and specialized oncology expertise. Their focus spans a wide range of therapeutic modalities, including immuno-oncology, targeted therapies, and complex biologics. The organization is recognized for its ability to conduct complex first-in-human trials and has contributed to the clinical development of numerous FDA-approved cancer therapies.